investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Regulation of microRNA expression by Mutant p53
Ashish Lal
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Karen Vousden
Beatson Institute (CRUK)
Glasgow, United Kingdom
Ashish Lal
National Cancer Institute (NIH)
Rockville, United States
Related projects
Shrikant Anant
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
Colorectum
Robert H. Singer
Mechanism of Actin mRNA Localization and Localized Translation in Neurons
Breast
Marie C. Lee
Development of the Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk
Breast
Eusebio Manchado-Robles
Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers
Trachea, bronchus and lung
Tim Alan Ahles
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & Smoking
Breast
Li Tang
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis
Breast
Mark I Greene
Carbohydrate Antigenic Biomarkers for Epithelial Cancers
Breast
Kent Hunter
Genetic Modifiers of Initiation and Progression of Mammary Cancer
Breast
Dihua Yu
Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC
Breast
